Therapeutic advancements for retinal disease

Video

Leo Semes, OD, FAAO, shares key highlights from his EyeCon 2022 presentation, "Advances in therapies for retinal disease."

Leo Semes, OD, FAAO, caught up with Optometry Times' to discuss key takeaways from his presentation, "Advances in therapies for retinal disease," which he co-presented with Drs. A. Paul Chous, Mohammad Rafieetary, and Diana Shectman, during EyeCon 2022 held in Marco Island, Flordida.

This transcript has been edited for clarity:

I'm Leo Semes, Professor Emeritus of optometry and vision science at the University of Alabama Birmingham. And my topic today, I'm going to be part of a panel talking about new therapies for retinal diseases.

And we're going to be talking specifically about neovascular problems, as well as intraocular tumors. And we're going to begin by talking about some of the previous treatments for age-related macular degeneration and proliferative diabetic retinopathy, where the idea was pretty much to stabilize the patient's visual acuity.

We had little 40 years ago with regard to guidance on preventive strategies. And today, some of the newer strategies allow us not only to stabilize the patient's vision in those cases, but also improve visual acuity. And with better visual performance, we have better outcomes and happier patients.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.